News About: Pharm. Industry
China's Joining to WTO Good Opportunity for Korean Company
How will China's joining to WTO affect to Korean Pharmaceutical Industry?
As China joined to WTO officially on 10th there is a diversity of opinion about the effect to pharmaceutical industry in Korea in the future...
KPMA Promote to Compose Consortium to Develop New Medicine
KPMA put premise that the corporation model which Korean Pharmaceutical Industry can continue its development is the one progresses fair transaction and the other one with development capability of research and decide...
GSK's Success of Localization Management Attract Attention.
As foreign capital companies with superior product and marketing power making inroads to Korean market created friction with Korean Pharmaceutical Industry due to their exclusive marketing & sales strategy GlaxoSmithK...
Profit of Listed Pharmaceutical Company Improved Continuously.
As of now, 1 year after the implementation of separation system management achievement of listed pharmaceutical companies have improved continuously including reformed profit system.
Yakup Daily collected manageme...
President of Lilly Korea Appointed to New Chairman of KRPIA
Mark H. Johnson, president of Lilly Korea was appointed to new chairman of Korea Research-Based Pharmaceutical Industry Association.
KRPIA held a directors meeting recently and announced that Mark H. Johnson was a...
SK compose bio fund of 12 billion dollars in China.
The China Daily reported that SK and Shanghai Science Technology Committee decided to compose fund for R&D of bio engineering industry with the scale of 12 billion dollars.
Chi-e cheng, president of SK China announ...
Nexgene to tie in research with Canadian research council.
Nexgene (Representative : Lee Sun-kyo), a plant bio-engineering venture company of Korea, announced on Nov. 14 that the company made an agreement with NRC (National Research Council) of Canada and PBI (Plant Biotechno...
Graduate From Prestigious Universities Apply for Sales Jobs
As the recruitment of new employees decreased drastically in all sectors of the industry due to economic stagnation, HR departments in pharmaceutical companies are very elated because qualified candidates are rushing ...
Clebudin to show excellent clinical results against B hepatitis.
Clebudin, a new therapeutic agent against B type hepatitis developed by Bukwang, has shown far outstanding clinical profiles compared to drugs already on markets. Its clinical study was reported by Prof. Lee Hyo-suk, ...
Cooperation Among Pharmaceutical Technology Trading Associations Is Urgent
The pharmaceutical technology trading sector, which is being actively advanced for the efficiency of the domestic pharmaceutical industry, has indicated that it should equip itself with a unified systematic system to ...
